oncology
Most Read
STAT Plus: ‘Every man and his dog’ does cell therapy. Vor’s new CEO says the company wants to be different
STAT Plus: As CAR-T changes lives, Medicare’s top official explains why it’s proving so hard to pay for it
STAT Plus: Q&A: Bristol-Myers’ top scientist on the future of cancer care
STAT Plus: Q&A: Repurposing existing drugs for new uses in cancer — for no profit
FDA warns against widely used ovarian cancer screening test
Top scientists lay out sweeping recommendations for ‘moonshot’ against cancer
